首页> 美国卫生研究院文献>Pharmaceutics >Flurbiprofen-Loaded Solid SNEDDS Preconcentrate for the Enhanced Solubility In-Vitro Dissolution and Bioavailability in Rats
【2h】

Flurbiprofen-Loaded Solid SNEDDS Preconcentrate for the Enhanced Solubility In-Vitro Dissolution and Bioavailability in Rats

机译:装载氟比洛芬的固体SNEDDS预浓缩物可增强大鼠的溶解度体外溶解度和生物利用度

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The aim of this work was to prepare and optimize a solid self-nanoemulsifying drug delivery system pre-concentrate (SSP) containing water-insoluble flurbiprofen (FL) using a novel pseudo-ternary phase diagram. The pseudo-ternary phase diagram, composed of FL as the drug and dispersion core, Kollisolv MCT 70 as the oil phase, and TPGS (tocopherol polyethylene glycol 1000 succinate) as the surfactant, was constructed for the determination of the SSP region. SSP was investigated in terms of particle size, physical state by differential scanning calorimetry (DSC) and powder X-ray diffraction (PXRD), in vitro dissolution and oral pharmacokinetics in rats. The determined SSP (FL/Kollisolv MCT 70/TPGS = 10/10/80, weight %) in the pseudo-ternary phase diagram had the melting point of 32.37 °C and uniform mean particle size of below 30 nm without any precipitation of FL in the dispersion. In the dissolution test, the SSP exhibited 95.70 ± 3.40% of release at 15 min, whereas the raw FL showed poor dissolution (i.e., 6.75 ± 1.30%) at that time point. In addition, the SSP showed the enhanced oral absorption (i.e., 1.93-fold increase in AUCinfinite) as compared to the suspension group of raw FL. Therefore, the developed SSP would be a promising drug delivery system with excellent solubilization, dissolution, and bioavailability for FL.
机译:这项工作的目的是使用新型拟三元相图制备和优化包含水不溶性氟比洛芬(FL)的固体自纳米乳化药物输送系统预浓缩物(SSP)。拟三元相图由FL作为药物和分散核,Kollisolv MCT 70作为油相,以及TPGS(生育酚聚乙二醇1000琥珀酸酯)作为表面活性剂组成,用于测定SSP区。通过大鼠的粒径,物理状态,差示扫描量热法(DSC)和粉末X射线衍射(PXRD),体外溶出度和口服药代动力学研究了SSP。在拟三元相图中测定的SSP(FL / Kollisolv MCT 70 / TPGS = 10/10/80,重量%)的熔点为32.37°C,平均粒径小于30 nm,没有FL沉淀在分散。在溶出度测试中,SSP在15分钟时的释放率为95.70±3.40%,而原始FL在该时间点显示出较差的溶出度(即6.75±1.30%)。另外,与未加工FL的悬浮液组相比,SSP显示出增强的口服吸收(即AUCinfinite增加1.93倍)。因此,开发的SSP将是一种有前途的药物输送系统,具有出色的FL增溶,溶解和生物利用度。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号